Elicio Therapeutics, Inc. Stock Performance

Open $3.21	Prev. Close $3.19	Circuit Range N/A
Day Range $3.15 - $3.26	Year Range $2.68 - $16.00	Volume 4,107
Average Traded $3.18

Elicio Therapeutics, Inc. Share Price Today

As of 10 August 2026, Elicio Therapeutics, Inc.'s share price is $3.17. The stock opened at $3.21, compared to its previous close of $3.19. During today's trading session, Elicio Therapeutics, Inc.'s share price traded between $3.15 and $3.26, with an average price of $3.21. Over the past 52 weeks, the stock has recorded a high of $16.00 and a low of $2.68. In terms of performance, Elicio Therapeutics, Inc.'s share price has declined by 75.74% over the last six months and is down 69.73% on a year-on-year basis.

Elicio Therapeutics, Inc. Share Price Chart

$3.15$3.26

Elicio Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap $48.62M	PE Ratio (TTM) -1.23	Dividend Yield N/A
EPS (TTM) $-2.58	Revenue (TTM) -$37.71M	Return On Equity (TTM) -2418.77%
Profit Margin 104.92%	Debt to Equity 4.96	Quarterly Earnings Growth YoY 46.48%

Elicio Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	N/A	-$10.92M	-$10.34M	-$10.74M	-$10.09M	-$8.04M
Net Profit	-$11.83M	-$7.23M	-$18.84M	-$11.21M	-$10.56M	-$10.08M
Net Profit Margin	N/A	66.18%	182.12%	104.41%	104.66%	125.33%
Income Change	N/A	38.88%	-160.59%	40.50%	5.78%	4.53%

Elicio Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars	2024	2025
Revenue	-$44.99M	-$37.71M
Net Profit	-$51.90M	-$39.57M
Net Profit Margin	115.36%	104.92%
Income Change	N/A	23.75%

About Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph nodetargeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trial to target seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph nodetargeted AMP peptide vaccine in preclinical studies for the treatment of mutant b-raf murine sarcoma viral oncogene homolog B1-driven cancers; and ELI-008, a multivalent lymph nodetargeted AMP peptide vaccine in preclinical studies for use in the treatment of mutated tumor protein p53 expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.

Elicio Therapeutics, Inc. Historical Returns

Month	Open	Close	Change %
Aug 2026	$2.84	$3.17	+13.19%
Jul 2026	$3.98	$2.81	-28.63%
Jun 2026	$11.53	$3.93	-65.16%
May 2026	$10.65	$11.28	+6.42%
Apr 2026	$10.78	$10.60	-1.21%
Mar 2026	$13.34	$10.73	-18.03%
Feb 2026	$7.91	$13.09	+69.23%
Jan 2026	$7.99	$7.74	-2.83%
Dec 2025	$9.27	$7.96	-14.64%
Nov 2025	$9.21	$9.32	+0.05%
Oct 2025	$10.87	$9.32	-13.70%
Sep 2025	$10.55	$10.80	+2.96%

ELTX Share Price FAQs

What is Elicio Therapeutics, Inc. share price today?

Elicio Therapeutics, Inc. share price today is $3.17 as on August 8, 2026 at 1:28 am IST.

What is the 52 week high and 52 week low of Elicio Therapeutics, Inc. stock?

The 52 week high of Elicio Therapeutics, Inc. stock is $16.00, while the 52 week low is $2.68 as of 8 Aug '26.

What is ELTX's market capitalisation today?

ELTX market capitalisation is $48.62M as of August 10, 2026, at 9:27 am IST.

What is ELTX's net income for the last quarter?

ELTX's net income for the last quarter is -0.01B USD.

What is the 5 year returns of ELTX?

The 5 year returns of ELTX is -97.12% as on 8 Aug '26.

What is the high & low stock price of ELTX today?

ELTX stock price hit a high of $3.26 and low of $3.15 as of 8 Aug '26.

Can I buy ELTX shares in India?

Yes. You can buy ELTX in India by opening an international trading account.